---
title: ESMO expert consensus statements on the screening and management of financial
  toxicity in patients with cancer
date: '2024-04-16'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38626634/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240417180658&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'BACKGROUND: Financial toxicity, defined as both the objective financial
  burden and subjective financial distress from a cancer diagnosis and its treatment,
  is a topic of interest in the assessment of the quality of life of patients with
  cancer and their families. Current evidence implicates financial toxicity in psychosocial,
  economic and other harms, leading to suboptimal cancer outcomes along the entire
  trajectory of diagnosis, treatment, supportive care, survivorship and palliation.
  ...'
disable_comments: true
---
BACKGROUND: Financial toxicity, defined as both the objective financial burden and subjective financial distress from a cancer diagnosis and its treatment, is a topic of interest in the assessment of the quality of life of patients with cancer and their families. Current evidence implicates financial toxicity in psychosocial, economic and other harms, leading to suboptimal cancer outcomes along the entire trajectory of diagnosis, treatment, supportive care, survivorship and palliation. ...